ChEMBL_ID,canonical_smiles,IC50,IC50_units,Assay_Description
CHEMBL281525,CCC(C)(O)C#Cc1nc(NCc2ccc(OC)c(OC)c2)c2ncn(C(C)C)c2n1,600.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL336776,CC(C)n1cnc2c(NCc3ccccc3)nc(C#CC3(O)CCCC3)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL3085240,COc1cccc(CNc2nc(N3CCC[C@@H]3CO)nc3c2ncn3C(C)C)c1,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL3085235,COc1cc(CNc2nc(N3CCC[C@@H]3CO)nc3c2ncn3C(C)C)cc(OC)c1,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL130161,COc1cc(CNc2nc(I)nc3c2ncn3C(C)C)cc(OC)c1,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL3085244,CC(C)n1cnc2c(NCc3ccccc3C(F)(F)F)nc(N3CCC[C@@H]3CO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL26513,CCC(C)(O)C#Cc1nc(Nc2ccc(Cl)c(Cl)c2)c2ncn(C(C)C)c2n1,500.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL2111870,CC(C)n1cnc2c(NCc3ccccc3)nc(N[C@H](CO)Cc3ccccc3)nc21,2000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL132948,Ic1nc(NCc2ccccc2)c2ncn(C3CCCC3)c2n1,100000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL130315,CC(C)n1cnc2c(NCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)nc(I)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL3085241,CC(C)n1cnc2c(NCc3ccc(Cl)cc3)nc(N3CCC[C@@H]3CO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL134239,CC(C)n1cnc2c(NCc3ccccc3)nc(C#CC3(O)CCCCC3)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL3085249,CC(C)n1cnc2c(N(Cc3ccccc3)Cc3ccccc3)nc(N3CCC[C@@H]3CO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL3085248,CC(C)n1cnc2c(Nc3ccc(Cl)c(Cl)c3)nc(N3CCC[C@@H]3CO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL335743,Nc1nc(Cl)c2ncn(C3CCCC3)c2n1,100000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL3085251,OC[C@H]1CCCN1c1nc(NCc2ccccc2)c2ncn(C3CCCC3)c2n1,500.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL3085252,CC(C)n1cnc2c(NCc3cccc(I)c3)nc(N3CCC[C@@H]3CO)nc21,160.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL134003,CC(C)n1cnc2c(NCc3ccccc3)nc(CCCCO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL133242,CC(C)n1cnc2c(NCc3ccccc3)nc(/C=C/CCCO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL130903,CC(C)n1cnc2c(Nc3cccc(Br)c3)nc(I)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL77369,CC(C)n1cnc2c(Nc3cccc(Cl)c3)nc(N3CCC[C@@H]3CO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL3085238,COc1ccc(CNc2nc(N3CCC[C@@H]3CO)nc3c2ncn3C(C)C)cc1,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL26564,CCC(C)(O)C#Cc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,340.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL2112682,CC(C)n1cnc2c(NCc3ccccc3)nc(N[C@@H](CO)Cc3ccccc3)nc21,1300.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL335966,CC(C)n1cnc2c(NCc3ccccc3)nc(N3CCC(O)C3)nc21,2400.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL14762,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL337715,CC(C)n1cnc2c(NCc3cccc(C(F)(F)F)c3)nc(I)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL2112683,CC(C)n1cnc2c(NCc3ccccc3)nc(N3CCC[C@H]3CO)nc21,2400.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL286491,CCC(C)(O)C#Cc1nc(NCc2ccc3c(c2)OCO3)c2ncn(C(C)C)c2n1,300.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL282193,CCC(C)(O)C#Cc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1,500.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL337411,CC(C)n1cnc2c(NCc3ccccc3)nc(C#CCCO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL130904,CC(C)n1cnc2c(Nc3ccccc3)nc(I)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL336995,CC(C)n1cnc2c(NCc3ccccc3C(F)(F)F)nc(I)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL3085231,CC(C)n1cnc2c(NCc3cccc(C(F)(F)F)c3)nc(N3CCC[C@H]3CO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL3085232,CC(C)n1cnc2c(NCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)nc(N3CCC[C@@H]3CO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL130597,CC(C)n1cnc2c(NCc3ccccc3)nc(N(CCO)Cc3ccccc3)nc21,8000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL132687,CC(C)n1cnc2c(NCc3ccccc3)nc(CCCO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL3085234,COc1ccccc1CNc1nc(N2CCC[C@@H]2CO)nc2c1ncn2C(C)C,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL133740,CC(C)n1cnc2c(N3CC=CCC3)nc(NCCO)nc21,100000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL2112678,CC(C)n1cnc2c(NCc3ccccc3)nc(N[C@H](C)CO)nc21,700.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL131031,C=CCN(C)c1nc(I)nc2c1ncn2C(C)C,14000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL3085242,OC[C@H]1CCCN1c1nc(NCc2ccccc2)c2ncn(C3CCCCC3)c2n1,13000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL131083,CC(C)n1cnc2c(NCc3ccc(C(F)(F)F)cc3)nc(I)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL3085243,CC(C)n1cnc2c(Nc3ccccc3)nc(N3CCC[C@@H]3CO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL129973,C=CCN(C)c1nc(NCCO)nc2c1ncn2C,100000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL134233,CCC(O)CCc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL338924,CCC(C)(O)CCc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL440717,CC(C)n1cnc2c(NCc3ccccc3)nc(NCC(O)c3ccccc3)nc21,2300.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL3085239,CC(C)[C@H](CO)Nc1nc(NCc2ccc3c(c2)OCO3)c2ncn(C(C)C)c2n1,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL336351,CC(C)n1cnc2c(NCc3ccccc3)nc(C#CC(C)(O)c3ccccc3)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL336176,C=CCN(C)c1nc(NCCO)nc2c1ncn2C(C)C,100000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL25840,CCC(C)(O)C#Cc1nc(NCc2ccc(Cl)c(Cl)c2)c2ncn(C(C)C)c2n1,500.0,nM,Compound was tested for its inhibitory activity against cyclin-dependent kinase 5
CHEMBL3085233,CC(C)n1cnc2c(NCc3ccc(C(F)(F)F)cc3)nc(N3CCC[C@@H]3CO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL133461,CCCCNc1nc(C#CC(C)(O)Cc2ccccc2)nc2c1ncn2C(C)C,340.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL336537,CCCCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,2300.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL335069,CC(C)n1cnc2c(NCc3ccccc3)nc(CCC(C)(O)c3ccccc3)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL2112679,CC(C)n1cnc2c(NC(CO)c3ccccc3)nc(N3CCC[C@H]3CO)nc21,,nM,Inhibition of cyclin-dependent kinase 5 (Not determined)
CHEMBL3085250,OC[C@H]1CCCN1c1nc(NCc2ccccc2)c2ncn(Cc3ccccc3)c2n1,100000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL280623,CCOc1ccc(Nc2nc(C#CC(C)(O)CC)nc3c2ncn3C(C)C)cc1,400.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL3085246,CC(C)(C)n1cnc2c(NCc3ccccc3)nc(N3CCC[C@@H]3CO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL2111871,CC(C)n1cnc2c(NCc3ccccc3)nc(N[C@H](CO)c3ccccc3)nc21,3500.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL2111872,CC(C)n1cnc2c(NCc3ccccc3)nc(N3CCC[C@@H]3CO)nc21,1300.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL3085237,CC(C)n1cnc2c(NCc3ccc4c(c3)OCO4)nc(N3CCC[C@@H]3CO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL130175,COc1ccc(CNc2nc(I)nc3c2ncn3C(C)C)cc1,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL445125,CCC(O)C#Cc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,,nM,Inhibition of cyclin-dependent kinase 5 (Not determined)
CHEMBL132243,CC(C)n1cnc2c(NCc3ccccc3)nc(C#CCO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL337291,CC(C)n1cnc2c(Cl)nc(I)nc21,100000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL134080,CC(C)n1cnc2c(NCc3ccccc3)nc(C#CCCCO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL132469,CC(C)n1cnc2c(NCc3ccccc3)nc(C#CCCCCO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL131697,CCCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,400.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL335852,CC(C)n1cnc2c(NCc3ccccc3)nc(CCCCCO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL2112681,CC(C)n1cnc2c(NCc3ccccc3)nc(N[C@@H](CO)c3ccccc3)nc21,6000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL133477,Ic1nc(NCc2ccccc2)c2ncn(Cc3ccccc3)c2n1,100000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL336117,C=CCN(C)c1nc(I)nc2c1ncn2C,40000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL334507,CC(C)n1cnc2c(Nc3ccc(Br)cc3)nc(N3CCCC3CO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL24484,CCC(C)(O)C#Cc1nc(NCc2ccc(Cl)cc2)c2ncn(C(C)C)c2n1,230.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL280074,Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21,3000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL2111873,CC(C)n1cnc2c(NCc3ccccc3)nc(N[C@@H](C)CO)nc21,35000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL3085245,CC(C)n1cnc2c(NCc3ccc(Cl)c(Cl)c3)nc(N3CCC[C@@H]3CO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL284899,CCC(C)(O)C#Cc1nc(Nc2ccccc2)c2ncn(C(C)C)c2n1,300.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL23317,CCC(C)(O)C#Cc1nc(Nc2ccc(OC)cc2)c2ncn(C(C)C)c2n1,300.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL436368,COc1ccc(CNc2nc(C#CC3(O)CCCCCC3)nc3c2ncn3C(C)C)cc1,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL440163,CC(C)n1cnc2c(Nc3ccc(Br)cc3)nc(I)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL133533,CC(C)n1cnc2c(NCc3ccccc3)nc(I)nc21,13000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL133055,COc1cccc(CNc2nc(I)nc3c2ncn3C(C)C)c1,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL2111869,CC(C)n1cnc2c(NC(CO)c3ccccc3)nc(N3CCC[C@@H]3CO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL422759,CCC(C)(O)C#Cc1nc(NCc2ccc(OC)cc2)c2ncn(C(C)C)c2n1,400.0,nM,Compound was tested for its inhibitory activity against cyclin-dependent kinase 5
CHEMBL23525,CCC(C)(O)C#Cc1nc(NCc2ccc(N(C)C)cc2)c2ncn(C(C)C)c2n1,260.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL336283,CCC(C)(O)C#Cc1nc(NCCc2ccc(OC)cc2)c2ncn(C(C)C)c2n1,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL335938,Ic1nc(NCc2ccccc2)c2ncn(C3CCCCC3)c2n1,100000.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL3085236,CC(C)n1cnc2c(NCc3cccc(Br)c3)nc(N3CCC[C@@H]3CO)nc21,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL282330,CCOc1ccc(CNc2nc(C#CC(C)(O)CC)nc3c2ncn3C(C)C)cc1,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL52387,CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,160.0,nM,Inhibitory activity against Cyclin-dependent kinase 5
CHEMBL338617,COc1ccccc1CNc1nc(I)nc2c1ncn2C(C)C,,nM,Inhibitory activity against Cyclin-dependent kinase 5; ND means Not determined
CHEMBL363711,CC(C)C(=O)Nc1ncc(C(C)C)s1,321.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL188172,CC(C)c1cnc(NC(=O)c2ccccc2)s1,1150.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL186120,CC(C)c1cnc(NC(=O)Oc2ccccc2)s1,1600.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL434917,CC(C)c1cnc(NC(=O)C(=O)c2ccccc2)s1,4580.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL186510,CC(C)c1cnc(NC(=O)Nc2ccccc2)s1,102.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL426972,CC(C)c1cnc(NC(=O)Cc2ccccc2)s1,64.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL185498,CCc1cnc(NC(=O)Cc2ccccc2)s1,621.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL365855,O=C(Cc1ccccc1)Nc1ncc(C2CCC2)s1,25.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL186511,O=C(Cc1ccccc1)Nc1ncc(C2CCCC2)s1,64.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL186846,O=C(Cc1ccccc1)Nc1ncc(C2CCCCC2)s1,390.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL186847,O=C(Cc1ccccc1)Nc1ncc(C2=CCCC2)s1,6530.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL186932,CCCCCc1cnc(NC(=O)Cc2ccccc2)s1,3270.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL186934,O=C(Cc1ccccc1)Nc1ncc(-c2ccccc2)s1,1570.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL362369,CC(=O)c1cnc(NC(=O)Cc2ccccc2)s1,7670.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL185734,CSc1cnc(NC(=O)Cc2ccccc2)s1,91.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL186201,O=C(Cc1ccccc1)Nc1ncc(Br)s1,900.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL363252,CN(C)c1cnc(NC(=O)Cc2ccccc2)s1,3990.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL186898,O=C(Cc1ccc2[nH]cnc2c1)Nc1ncc(C2CCC2)s1,7.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL363954,O=C(Cc1ccc2ncccc2c1)Nc1ncc(C2CCC2)s1,10.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL186470,Cc1nc2ccc(CC(=O)Nc3ncc(C4CCC4)s3)cc2s1,12.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL184404,O=C(Cc1cccc2cnccc12)Nc1ncc(C2CCC2)s1,13.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL186240,O=C(Cc1c[nH]c2ccccc12)Nc1ncc(C2CCC2)s1,16.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL187903,Cc1cc2ncn(CC(=O)Nc3ncc(C4CCC4)s3)c2cc1C,13.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL364338,O=C(Cn1ccc2ccccc21)Nc1ncc(C2CCC2)s1,48.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL185470,O=C(Nc1ccccc1)Nc1ncc(C2CCC2)s1,183.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL187015,O=C(Nc1ccc2ncccc2c1)Nc1ncc(C2CCC2)s1,44.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL359591,O=C(Nc1ccc2cnccc2c1)Nc1ncc(C2CCC2)s1,44.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL187256,O=C(Nc1ncc(C2CCC2)s1)Nc1cccc2ncccc12,13.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL364213,O=C(Nc1ncc(C2CCC2)s1)Nc1cccc2cnccc12,8.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL186342,O=C(Nc1ncc(C2CCC2)s1)Nc1cccc2ccncc12,5.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL363283,O=C(Nc1ncc(C2CCC2)s1)Nc1cccc2c[nH]nc12,190.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL186371,O=C(Nc1ncc(C2CCC2)s1)Nc1cccc2[nH]nnc12,41.0,nM,Concentration required for inhibition of cyclin-dependent kinase 5 was measured by scintillation proximity assay
CHEMBL210540,Cc1cc(-c2cnc(Nc3cnc(CN4CCN(C)CC4)cn3)s2)nc(OC2CCCCC2)n1,3000.0,nM,Inhibition of CDK5
CHEMBL427045,Cc1cc(-c2cnc(Nc3ccccn3)s2)nc(OC2CCCCC2)n1,10000.0,nM,Inhibition of CDK5
CHEMBL212049,Cc1cnc(OC2CCCCC2)nc1-c1cnc(Nc2ccccn2)s1,10000.0,nM,Inhibition of CDK5
CHEMBL424696,c1ccc(Nc2ncc(-c3ccnc(OC4CCCCC4)n3)s2)nc1,34.0,nM,Inhibition of CDK5
CHEMBL386661,CNc1ncc2cc(-c3cc(C(=O)Nc4cc(C(F)(F)F)ccc4OC4CCN(C)CC4)ccc3C)ccc2n1,25000.0,nM,Inhibition of CDK5 by HTRF kinase assay
CHEMBL215943,Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2nc(NCCN3CCOCC3)ncc2c1,25000.0,nM,Inhibition of CDK5 by HTRF kinase assay
CHEMBL373882,CNc1ncnc(-c2cccnc2Oc2ccc(F)c(C(=O)Nc3cc(C(F)(F)F)ccc3N(C)CCCN(C)C)c2)n1,100000.0,nM,Inhibition of CDK5
CHEMBL386637,CN(C)[C@H]1CCCN(c2ccc(C(F)(F)F)cc2NC(=O)c2cc(C#Cc3cnc(N)nc3)ccc2F)C1,100000.0,nM,Inhibition of CDK5
CHEMBL410295,Cc1cccc(C)c1-n1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n2c3ccccc3nc12,10000.0,nM,Inhibition of CDK5 by HTRF assay
CHEMBL272888,Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1,25000.0,nM,Inhibition of CDK5 by HTRF assay
CHEMBL427901,CCNC(=O)O[C@@H](C)[C@H]1c2ccccc2-c2c3c(c4c([nH]c5ccccc54)c21)CNC3=O,4329.0,nM,Inhibition of CDK5
CHEMBL505896,COc1cc2c(Oc3ccc(-c4cnc(Cc5ccccc5)n(C)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,100000.0,nM,Inhibition of CDK5
CHEMBL453737,COc1cc2c(Oc3ccc(-c4cnc(Nc5ccc(F)cc5)n(C)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,100000.0,nM,Inhibition of CDK5
CHEMBL447602,COc1cc2c(Oc3ccc(-c4cnc(Nc5ccc(F)cc5)n(C)c4=O)nc3)ccnc2cc1OCCCN1CCOCC1,100000.0,nM,Inhibition of CDK5
CHEMBL516901,O=c1[nH]c2[nH]cc(-c3ccc(Cl)cc3)c2n2cccc12,50000.0,nM,Inhibition of CDK5
CHEMBL453402,COc1ccc(-c2c[nH]c3[nH]c(=O)c4cccn4c23)cc1OC,50000.0,nM,Inhibition of CDK5
CHEMBL477954,O=c1[nH]c2occ(-c3ccc(Br)cc3)c2n2cccc12,50000.0,nM,Inhibition of CDK5
CHEMBL517818,O=c1[nH]c2occ(-c3ccc(F)cc3)c2n2cccc12,50000.0,nM,Inhibition of CDK5
CHEMBL517669,Cc1ccc(-c2coc3[nH]c(=O)c4cccn4c23)cc1,50000.0,nM,Inhibition of CDK5
CHEMBL478516,COc1ccc(-c2coc3[nH]c(=O)c4cccn4c23)cc1,50000.0,nM,Inhibition of CDK5
CHEMBL478517,O=c1[nH]c2occ(-c3ccc(Cl)c(Cl)c3)c2n2cccc12,50000.0,nM,Inhibition of CDK5
CHEMBL478704,COc1ccc(-c2coc3[nH]c(=O)c4cccn4c23)cc1OC,50000.0,nM,Inhibition of CDK5
CHEMBL34267,COc1ccc(-c2csc3c2-n2cccc2C3=O)cc1OCc1ccccc1,,,Inhibition of CDK5
CHEMBL287508,COc1ccc(-c2csc3c2-n2cccc2C3=O)cc1O,,,Inhibition of CDK5
CHEMBL476236,O=C1c2[nH]cc(-c3ccc(Cl)cc3)c2-n2cccc21,50000.0,nM,Inhibition of CDK5
CHEMBL35864,COc1ccc(-c2c[nH]c3c2-n2cccc2C3=O)cc1OC,50000.0,nM,Inhibition of CDK5
CHEMBL507162,COc1ccc(-c2c[nH]c3c2-n2cccc2C3=O)cc1OCc1ccccc1,50000.0,nM,Inhibition of CDK5
CHEMBL518732,COc1ccc(-c2c[nH]c3c2-n2cccc2C3=O)cc1O,30000.0,nM,Inhibition of CDK5
CHEMBL286423,COc1ccc(-c2coc3c2-n2cccc2C3=O)cc1OC,50000.0,nM,Inhibition of CDK5
CHEMBL476851,COc1ccc(-c2c[nH]c3c2-n2cccc2/C3=N/O)cc1OCc1ccccc1,14000.0,nM,Inhibition of CDK5
CHEMBL444169,COc1ccc(-c2c[nH]c3c2-n2cccc2/C3=N/O)cc1O,3200.0,nM,Inhibition of CDK5
CHEMBL221959,C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12,10000.0,nM,Inhibition of Cdk5
CHEMBL516640,COc1ccc(-n2cnc3ccc(-c4nnc(SCc5cccc(C#N)c5)o4)cc32)cc1,10000.0,nM,Inhibition of CDK5
CHEMBL574588,Cc1ccc(-c2ccc3occ(-c4ccc([S@+](C)[O-])cc4)c3c2)o1,10000.0,nM,Inhibition of CDK5 by [gamma-33-P]ATP based assay
CHEMBL574613,CC[S@+]([O-])c1ccc(-c2coc3ccc(-c4ccc(C)o4)cc23)cc1,10000.0,nM,Inhibition of CDK5 by [gamma-33-P]ATP based assay
CHEMBL240799,O=C1Nc2ccccc2CN1c1csc(-c2ccncc2)n1,79.0,nM,Inhibition of human CDK5
CHEMBL235764,O=c1[nH]c2ccccc2cc1-c1csc(-c2ccncc2)n1,54.0,nM,Inhibition of human CDK5
CHEMBL577030,CCOC(=O)c1cc(-c2csc(-c3ccncc3)n2)c(=O)[nH]c1C,131.0,nM,Inhibition of human CDK5
CHEMBL1077347,N#Cc1c(N)cc2[nH]nc(N)c2c1-c1ccccc1,11000.0,nM,Inhibition of CDK5
CHEMBL1080583,CCC(CO)Nc1nc(Nc2cccc(-c3ccccn3)c2)c2ncn(C(C)C)c2n1,80.0,nM,Inhibition of CDK5
CHEMBL409450,O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O,83.0,nM,Inhibition of CDK5
CHEMBL373834,O=Nc1c(-c2c(O)[nH]c3c(Br)cccc23)[nH]c2ccccc12,33000.0,nM,Inhibition of CDK5
CHEMBL1081198,O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1)Nc1cccc(C(F)(F)F)c1,50000.0,nM,Inhibition of CDK5 after 1 hr
CHEMBL1090360,O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1,1000.0,nM,Inhibition of CDK5
CHEMBL225519,O=C1NCCc2[nH]c(-c3ccncc3)cc21,460.0,nM,Inhibition of cdk5
CHEMBL1242977,CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)c3cccc(C(F)(F)F)c3)cc2C)n1,8000.0,nM,Inhibition of CDK5 by HTRF assay
CHEMBL1243200,CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)c3ccccc3Nc3ccccc3)cc2)n1,1000.0,nM,Inhibition of CDK5 by HTRF assay
CHEMBL1243326,CNc1nccc(-c2cccnc2Oc2ccc(Nc3nnc(-c4ccc(F)cc4)c4ccccc34)cc2)n1,25000.0,nM,Inhibition of CDK5 by HTRF assay
CHEMBL280074,Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21,3000.0,nM,Inhibition of CDK5
CHEMBL14762,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,160.0,nM,Inhibition of CDK5
CHEMBL1242367,CCNc1cc(N[C@H]2CC[C@@H](O)CC2)nc(Nc2ccc3c(ccn3Cc3ccccc3)c2)n1,25000.0,nM,Inhibition of CDK5
CHEMBL258805,COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2,65.0,nM,Inhibition of CDK5
CHEMBL50894,O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1,40.0,nM,Inhibition of CDK5
CHEMBL1241758,O=C(Nc1cc(C2CCC2)c[nH]1)Nc1cccc2ccncc12,5.0,nM,Inhibition of CDK5
CHEMBL362560,COc1ccc(-c2[nH]nc3c2C(=O)c2c(NC(=O)NNC(=O)c4ccc(O)cc4)cccc2-3)cc1,5.0,nM,Inhibition of CDK5
CHEMBL115220,O=C(Cc1ccc2ccccc2c1)Nc1cc(C2CC2)n[nH]1,114.0,nM,Inhibition of CDK5
CHEMBL1241935,CC1(C)CC2(C)Nc3cc(-c4ccc5c(c4)NC4(C)CC(C)(C)NC(=S)N54)ccc3N2C(=S)N1,25000.0,nM,Inhibition of CDK5
CHEMBL259850,COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1,100000.0,nM,Inhibition of CDK5 at 10 mM
CHEMBL14762,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,160.0,nM,Inhibition of CDK5
CHEMBL50498,Nc1nccc(-c2c[nH]c3cccc(O)c23)n1,3500.0,nM,Inhibition of CDK5
CHEMBL1173442,C[C@H]1C/C=C/[C@@H](O)[C@@H](O)CC/C=C/c2cc(O)cc(O)c2C(=O)O1,6000.0,nM,Inhibition of CDK5
CHEMBL2205766,CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1,10000.0,nM,Inhibition of CDK5
CHEMBL605320,c1ccc2c(c1)nc(NCCN1CCOCC1)c1c3ccccc3[nH]c21,50000000.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL2297165,CCN(Cc1cn2ccccc2n1)Cc1nc2cc(OC)c(OC)cc2c(=O)[nH]1,50000000.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL361708,NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Br)cc32)N1,30.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL464381,CC1=C(O)[C@@H](C/C(C)=C/CCC(C)/C=C/C=C(\C)CCCc2ccoc2)OC1=O,25118.86,nM,Inhibition of human recombinant CDK5 using histone H1 as substrate and [gamma33P]-ATP after 20 mins by scintillation counting
CHEMBL464381,CC1=C(O)[C@@H](C/C(C)=C/CCC(C)/C=C/C=C(\C)CCCc2ccoc2)OC1=O,25000.0,nM,Inhibition of human recombinant CDK5 using histone H1 as substrate and [gamma33P]-ATP after 20 mins by scintillation counting
CHEMBL2321962,O=C1Nc2c(Br)cccc2/C1=C1/Nc2cc(C(=O)O)ccc2/C1=N\O,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321960,COC(=O)c1ccc2c(c1)NC(=C1\C(=O)Nc3c(Br)cccc31)/C2=N/O,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321957,COC(=O)c1ccc2c(c1)C(=N\O)/C(=C1/C(=O)N(C)c3c(Br)cccc31)N2,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL1233659,O=C1Nc2c(Br)cccc2/C1=C1/Nc2ccc(C(=O)O)cc2/C1=N\O,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321956,O=C1Nc2c(cccc2C(F)(F)F)/C1=C1/Nc2ccc(-c3nnn[nH]3)cc2/C1=N\O,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321955,N#Cc1ccc2c(c1)C(=N\O)/C(=C1/C(=O)Nc3c1cccc3C(F)(F)F)N2,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321954,COC(=O)c1ccc2c(c1)C(=N\O)/C(=C1/C(=O)Nc3c1cccc3C(F)(F)F)N2,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321953,COC(=O)c1ccc2c(c1)C(=N\O)/C(=C1/C(=O)Nc3c(Br)cccc31)N2,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL213454,Cn1c(O)c(-c2[nH]c3ccccc3c2N=O)c2cccc(Br)c21,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321949,O=C1Nc2c(cccc2C(F)(F)F)/C1=C1/Nc2ccccc2/C1=N\O,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321947,O=C1Nc2c(Br)cccc2/C1=C1/Nc2ccc(CO)cc2C1=O,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321946,O=C1Nc2c(cccc2C(F)(F)F)/C1=C1/Nc2cc(C(=O)O)ccc2C1=O,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321945,O=C1Nc2c(Br)cccc2/C1=C1/Nc2cc(C(=O)O)ccc2C1=O,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL2322019,COC(=O)c1ccc2c(c1)N/C(=C1\C(=O)Nc3c1cccc3C(F)(F)F)C2=O,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321975,COC(=O)c1ccc2c(c1)N/C(=C1\C(=O)Nc3c(Br)cccc31)C2=O,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321974,O=C1Nc2ccccc2/C1=C1/Nc2cc(C(=O)O)ccc2C1=O,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321973,COC(=O)c1ccc2c(c1)C(=O)/C(=C1/C(=O)N(C)c3c(Br)cccc31)N2,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321972,O=C1Nc2c(cccc2C(F)(F)F)/C1=C1/Nc2ccc(-c3nnn[nH]3)cc2C1=O,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321971,N#Cc1ccc2c(c1)C(=O)/C(=C1/C(=O)Nc3c1cccc3C(F)(F)F)N2,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321970,COC(=O)c1ccc2c(c1)C(=O)/C(=C1/C(=O)Nc3c1cccc3C(F)(F)F)N2,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321969,COC(=O)c1ccc2c(c1)C(=O)/C(=C1/C(=O)Nc3c(Br)cccc31)N2,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321967,COC(=O)c1ccc2c(c1)C(=O)/C(=C1/C(=O)Nc3ccccc31)N2,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL375870,Cn1c(O)c(C2=Nc3ccccc3C2=O)c2cccc(Br)c21,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL373834,O=Nc1c(-c2c(O)[nH]c3c(Br)cccc23)[nH]c2ccccc12,10000.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321968,O=C1Nc2ccccc2/C1=C1/Nc2ccc(C(=O)O)cc2C1=O,3400.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321959,O=C1Nc2ccccc2/C1=C1/Nc2cc(C(=O)O)ccc2/C1=N\O,3300.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321963,O=C1Nc2c(cccc2C(F)(F)F)/C1=C1/Nc2cc(C(=O)O)ccc2/C1=N\O,3100.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321961,COC(=O)c1ccc2c(c1)NC(=C1\C(=O)Nc3c1cccc3C(F)(F)F)/C2=N/O,1700.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321878,O=C1Nc2c(cccc2C(F)(F)F)/C1=C1/Nc2ccc(C(=O)O)cc2/C1=N\O,1600.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321965,O=C1Nc2c(Br)cccc2/C1=C1/Nc2ccc(/C=N\O)cc2/C1=N\O,600.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321952,O=C1Nc2ccccc2/C1=C1/Nc2ccc(C(=O)O)cc2/C1=N\O,530.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321951,COC(=O)c1ccc2c(c1)C(=N\O)/C(=C1/C(=O)Nc3ccccc31)N2,520.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321964,O=C1Nc2c(Br)cccc2/C1=C1/Nc2ccc(CO)cc2/C1=N\O,400.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321958,CN1C(=O)/C(=C2\Nc3ccc(C(=O)O)cc3\C2=N/O)c2cccc(Br)c21,200.0,nM,Inhibition of human recombinant CDK5
CHEMBL2321948,O=C1Nc2c(Br)cccc2/C1=C1/Nc2ccc(/C=N/O)cc2C1=O,200.0,nM,Inhibition of human recombinant CDK5
CHEMBL409450,O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O,83.0,nM,Inhibition of human recombinant CDK5
CHEMBL2391102,CC(=O)Nc1cc(-c2nnc(SCc3ccc(-c4ccccc4C#N)cc3)o2)ccn1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391101,CC(=O)Nc1cc(-c2nnc(SCc3cccc(C#N)c3)o2)ccn1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391100,CC(=O)Nc1cc(-c2nnc(SCc3ccccc3)o2)ccn1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391099,c1ccc(-c2ccc(CSc3nnc(-c4ccncc4)o3)cc2)cc1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391098,N#Cc1cc(F)ccc1-c1ccc(CSc2nnc(-c3ccncc3)o2)cc1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391131,COc1ccc(-c2ccc(CSc3nnc(-c4ccncc4)o3)cc2)cc1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2390958,N#Cc1ccc(-c2ccc(CSc3nnc(-c4ccncc4)o3)cc2)cc1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391132,N#Cc1cccc(-c2ccc(CSc3nnc(-c4ccncc4)o3)cc2)c1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391133,O=[N+]([O-])c1ccccc1-c1ccc(CSc2nnc(-c3ccncc3)o2)cc1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391117,Fc1cc(F)cc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)c1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391118,COc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)c(C#N)c1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391119,COc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)cc1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391120,O=[N+]([O-])c1cccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)c1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391121,N#Cc1cccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)c1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391122,O=[N+]([O-])c1ccccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCO4)o2)cc1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391123,c1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)cc1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391124,Fc1cc(F)cc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)c1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391125,COc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)c(C#N)c1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391126,COc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)cc1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391127,N#Cc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)cc1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391128,O=[N+]([O-])c1cccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)c1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391130,N#Cc1cccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)c1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL2391129,O=[N+]([O-])c1ccccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1,100000.0,nM,Inhibition of human recombinant Cdk5/p35 by FRET assay
CHEMBL191003,Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F,12.59,nM,Inhibition of CDK5 (unknown origin)
CHEMBL2426395,COc1ccc(NC(=S)NC(=O)c2cn(-c3ccccc3)nc2-c2ccc(OC)cc2)cc1,1093.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate after 10 mins in presence of [gamma-32P]-ATP
CHEMBL2426391,COc1ccc(NC(=S)NC(=O)c2cn(-c3ccccc3)nc2-c2ccc(F)cc2)cc1,1178.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate after 10 mins in presence of [gamma-32P]-ATP
CHEMBL2426387,COc1ccc(NC(=S)NC(=O)c2cn(-c3ccccc3)nc2-c2ccc(Cl)cc2)cc1,1356.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate after 10 mins in presence of [gamma-32P]-ATP
CHEMBL2426383,COc1ccc(NC(=S)NC(=O)c2cn(-c3ccccc3)nc2-c2ccc(C)cc2)cc1,1420.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate after 10 mins in presence of [gamma-32P]-ATP
CHEMBL2426399,COc1ccc(NC(=S)NC(=O)c2cn(-c3ccccc3)nc2-c2ccccc2)cc1,1502.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate after 10 mins in presence of [gamma-32P]-ATP
CHEMBL3219057,COc1ccc2[nH]c(-c3ccccc3)c(-c3ccncc3)c2n1,10000.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL3219058,COc1ccc2[nH]c(-c3ccccc3O)c(-c3ccncc3)c2n1,10000.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL3219059,COc1ccc2[nH]c(-c3cccc(O)c3)c(-c3ccncc3)c2n1,10000.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL3219060,COc1ccc2[nH]c(-c3ccc(O)cc3)c(-c3ccncc3)c2n1,10000.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL3219061,COc1ccc2[nH]c(-c3cccc(F)c3)c(-c3ccncc3)c2n1,10000.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL3219062,COc1ccc2[nH]c(-c3ccc4cc(O)ccc4c3)c(-c3ccncc3)c2n1,10000.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL3219063,COc1ccc2[nH]c(-c3cc(O)cc(O)c3)c(-c3ccncc3)c2n1,10000.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL3219064,COc1ccc2[nH]c(-c3cccc(O)c3)c(-c3cccnc3)c2n1,10000.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL3219065,COc1ccc2[nH]c(-c3cccc(O)c3)c(-c3ccccn3)c2n1,10000.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL3297830,Cn1c2c(O)cccc2c(=O)c2c3c(c4c(c21)C=CC(C)(C)O4)C=C(O)C(C)(C)O3,10000.0,nM,Inhibition of CDK5 (unknown origin) assessed as inhibition of phosphate incorporation into substrate in presence of radiolabeled ATP
CHEMBL3297831,Cn1c2c(O)cccc2c(=O)c2c3occc3c3c(c21)C=CC(C)(C)O3,10000.0,nM,Inhibition of CDK5 (unknown origin) assessed as inhibition of phosphate incorporation into substrate in presence of radiolabeled ATP
CHEMBL452220,CC1(C)C=Cc2c(cc(O)c3c(=O)c4cccc(O)c4[nH]c23)O1,10000.0,nM,Inhibition of CDK5 (unknown origin) assessed as inhibition of phosphate incorporation into substrate in presence of radiolabeled ATP
CHEMBL3297832,COc1c(O)ccc2c(=O)c3c(O)cc4c(c3[nH]c12)C=CC(C)(C)O4,9000.0,nM,Inhibition of CDK5 (unknown origin) assessed as inhibition of phosphate incorporation into substrate in presence of radiolabeled ATP
CHEMBL409450,O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O,85.0,nM,Inhibition of CDK5 (unknown origin) assessed as inhibition of phosphate incorporation into substrate in presence of radiolabeled ATP
CHEMBL3589653,O=C(O)c1nc2ccccc2c2[nH]c3ccccc3c12,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589654,CC(C)(C)c1ccc2[nH]c3c4ccccc4nc(C(=O)O)c3c2c1,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589655,O=C(O)c1nc2ccccc2c2[nH]c3ccc(C(F)(F)F)cc3c12,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589656,O=C(O)c1nc2ccccc2c2[nH]c3ccc([N+](=O)[O-])cc3c12,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589657,Cc1ccc2[nH]c3c4ccccc4nc(C(=O)O)c3c2c1,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589658,O=C(O)c1ccc2[nH]c3c4ccccc4nc(C(=O)O)c3c2c1,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589659,O=C(O)c1nc2ccc(I)cc2c2[nH]c3ccc(Cl)cc3c12,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589660,O=C(O)c1nc2ccccc2c2[nH]c3c(Cl)cccc3c12,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589661,O=C(O)c1nc2ccccc2c2[nH]c3c(Br)cccc3c12,100000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589662,O=C(O)c1nc2ccccc2c2[nH]c3c(I)cccc3c12,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589663,COc1cccc2c1[nH]c1c3ccccc3nc(C(=O)O)c21,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589664,COc1ccc2c(c1)nc(C(=O)O)c1c3cccc(F)c3[nH]c21,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589665,COc1ccc2c(c1)nc(C(=O)O)c1c3cccc(Cl)c3[nH]c21,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589666,COc1ccc2c(c1)nc(C(=O)O)c1c3cccc(Br)c3[nH]c21,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589667,COc1ccc2c(c1)nc(C(=O)O)c1c3cccc(I)c3[nH]c21,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589668,O=C(O)c1nc2cc(Cl)ccc2c2[nH]c3c(Cl)cccc3c12,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589669,CCOc1ccc2c(c1)nc(C(=O)O)c1c3cccc(Cl)c3[nH]c21,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589670,O=C(O)c1nc2ccc(I)cc2c2[nH]c3c(F)cccc3c12,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589671,O=C(O)c1nc2ccc(I)cc2c2[nH]c3c(Cl)cccc3c12,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589672,O=C(O)c1nc2ccc(I)cc2c2[nH]c3c(Br)cccc3c12,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589673,COc1ccc2nc(C(=O)O)c3c4cccc(Cl)c4[nH]c3c2c1,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589674,COc1cccc(-c2ccc3nc(C(=O)O)c4c5cccc(Cl)c5[nH]c4c3c2)c1,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589675,COc1ccc(-c2ccc3nc(C(=O)O)c4c5cccc(Cl)c5[nH]c4c3c2)cc1,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589774,O=C(O)c1nc2ccsc2c2[nH]c3c(Cl)cccc3c12,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3589775,O=C(O)c1nc2cccnc2c2[nH]c3c(Br)cccc3c12,10000.0,nM,Inhibition of human recombinant CDK5 using [gamma-33P]ATP as substrate after 30 mins by scintillation counting analysis
CHEMBL3673435,COc1cc(F)ccc1-c1ccnc(NC(=O)C2CCC(NC(C)=O)C2)c1,1337.0,nM,"In Vitro Kinase Inhibition Assay: In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services providers in order to offer in vitro kinase activity assay services, e.g. the assays offered by Millipore Inc. (worldwide website www(dot)millipore.com), ProQinase GmbH (worldwide website www(dot)proqinase.de) and others. All kinase assays were performed in 96-well FlashPlates from Perkin Elmer/NEN (Boston, Mass., USA) in a 50ul reaction volume. The reaction mixture was pipetted in four steps in the following order: 20ul of assay buffer (standard buffer),5ul of ATP solution (in H2O, 5 ul of test compound (in 10% DMSO), 10ul of substrate/10ul of enzyme solution (premixed)The assay for all enzymes contained 60 mM HEPES-NaOH (pH 7.5), 3 mM MgCl2, 3 mM MnCl2, 3uM Na-Orthovanadate, 1.2 mM DTT, 50 ug/ml PEG2000, 1 uM [33P]-ATP (approx. 5x1005 cpm per well)."
CHEMBL3673434,COc1cc(F)ccc1-c1ccnc(NC(=O)[C@H]2CCC[C@@H](NC(C)=O)C2)c1,1077.0,nM,"In Vitro Kinase Inhibition Assay: In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services providers in order to offer in vitro kinase activity assay services, e.g. the assays offered by Millipore Inc. (worldwide website www(dot)millipore.com), ProQinase GmbH (worldwide website www(dot)proqinase.de) and others. All kinase assays were performed in 96-well FlashPlates from Perkin Elmer/NEN (Boston, Mass., USA) in a 50ul reaction volume. The reaction mixture was pipetted in four steps in the following order: 20ul of assay buffer (standard buffer),5ul of ATP solution (in H2O, 5 ul of test compound (in 10% DMSO), 10ul of substrate/10ul of enzyme solution (premixed)The assay for all enzymes contained 60 mM HEPES-NaOH (pH 7.5), 3 mM MgCl2, 3 mM MnCl2, 3uM Na-Orthovanadate, 1.2 mM DTT, 50 ug/ml PEG2000, 1 uM [33P]-ATP (approx. 5x1005 cpm per well)."
CHEMBL3651158,COc1cc2cc3c(nc2cc1OC)C1=C([Si](C)(C)C)C(=O)CC1CC3O,3300.0,nM,"Enzyme Inhibition Assay: The tests are carried out as follows: the enzyme to be assayed was purified, for example by affinity chromatography on agarose beads. The catalytic activity was measured using radiolabeled ATP, at a standard final concentration. The test compounds were added at various concentrations making it possible to establish dose-response curves (activity of the enzyme as a function of the concentration)."
CHEMBL3651154,C[Si](C)(C)C1=C2c3nc4ccccc4cc3C(O)CC2CC1=O,1950.0,nM,"Enzyme Inhibition Assay: The tests are carried out as follows: the enzyme to be assayed was purified, for example by affinity chromatography on agarose beads. The catalytic activity was measured using radiolabeled ATP, at a standard final concentration. The test compounds were added at various concentrations making it possible to establish dose-response curves (activity of the enzyme as a function of the concentration)."
CHEMBL3651155,C[Si](C)(C)C1=C2c3nc4ccccc4cc3C(Cl)CC2CC1=O,63000.0,nM,"Enzyme Inhibition Assay: The tests are carried out as follows: the enzyme to be assayed was purified, for example by affinity chromatography on agarose beads. The catalytic activity was measured using radiolabeled ATP, at a standard final concentration. The test compounds were added at various concentrations making it possible to establish dose-response curves (activity of the enzyme as a function of the concentration)."
CHEMBL3651156,COc1ccc2nc3c(cc2c1)C(O)CC1CC(=O)C([Si](C)(C)C)=C31,4000.0,nM,"Enzyme Inhibition Assay: The tests are carried out as follows: the enzyme to be assayed was purified, for example by affinity chromatography on agarose beads. The catalytic activity was measured using radiolabeled ATP, at a standard final concentration. The test compounds were added at various concentrations making it possible to establish dose-response curves (activity of the enzyme as a function of the concentration)."
CHEMBL3651154,C[Si](C)(C)C1=C2c3nc4ccccc4cc3C(O)CC2CC1=O,26000.0,nM,"Enzyme Inhibition Assay: The tests are carried out as follows: the enzyme to be assayed was purified, for example by affinity chromatography on agarose beads. The catalytic activity was measured using radiolabeled ATP, at a standard final concentration. The test compounds were added at various concentrations making it possible to establish dose-response curves (activity of the enzyme as a function of the concentration)."
CHEMBL3651154,C[Si](C)(C)C1=C2c3nc4ccccc4cc3C(O)CC2CC1=O,3000.0,nM,"Enzyme Inhibition Assay: The tests are carried out as follows: the enzyme to be assayed was purified, for example by affinity chromatography on agarose beads. The catalytic activity was measured using radiolabeled ATP, at a standard final concentration. The test compounds were added at various concentrations making it possible to establish dose-response curves (activity of the enzyme as a function of the concentration)."
CHEMBL3651157,COc1ccc2cc3c(nc2c1)C1=C([Si](C)(C)C)C(=O)CC1CC3O,4800.0,nM,"Enzyme Inhibition Assay: The tests are carried out as follows: the enzyme to be assayed was purified, for example by affinity chromatography on agarose beads. The catalytic activity was measured using radiolabeled ATP, at a standard final concentration. The test compounds were added at various concentrations making it possible to establish dose-response curves (activity of the enzyme as a function of the concentration)."
CHEMBL189963,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,10000.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL1801932,CC(C)c1cnn2c(NCc3ccccc3)cc(NCCCCCCN)nc12,3700.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL2103840,CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12,45.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL3775861,CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(NCc3ccc(-c4ccccn4)cc3)nc12,3600.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL3774636,COc1ccc(CNc2nc(NCc3ccc(-c4ccccn4)cc3)c3[nH]nc(C(C)C)c3n2)cc1,4415.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL3775467,CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(N3CCN(CCO)CC3)nc12,422.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL3774503,CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(N[C@H]3CC[C@H](N)CC3)nc12,179.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL3775657,CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(NCCN(C)C)nc12,2136.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL3774949,CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(N3CCNCC3)nc12,119.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL3775608,CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(NCC(N)CO)nc12,17.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL3775223,CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(N[C@@H]3CCCC[C@H]3N)nc12,44.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL3775470,CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(NCCN)nc12,8.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL3774979,CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(N3CCCCC3CCO)nc12,37.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL3775681,CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(N3CCSCC3)nc12,114.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL3775509,CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(N3CCOCC3)nc12,5.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL3775677,CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(NCC(O)CO)nc12,21.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL3774932,CCC(CO)Nc1nc(NCc2ccc(-c3ccccn3)cc2)c2[nH]nc(C(C)C)c2n1,9.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL3775792,CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(NCC(C)(C)O)nc12,1.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL3774632,CC(O)CNc1nc(NCc2ccc(-c3ccccn3)cc2)c2[nH]nc(C(C)C)c2n1,5.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL3775502,CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(NCCO)nc12,49.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL3775606,CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(S(C)(=O)=O)nc12,165.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL3775479,CSc1nc(NCc2ccc(-c3ccccn3)cc2)c2[nH]nc(C(C)C)c2n1,229.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL3774434,CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)ncnc12,183.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL518800,CC[C@H](CO)Nc1nc(NCc2ccc(-c3ccccn3)cc2)c2ncn(C(C)C)c2n1,225.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL14762,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,1069.0,nM,Inhibition of CDK5 (unknown origin) using histone H1 as substrate in presence of [gamma33P]-ATP
CHEMBL2103840,CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12,1.0,nM,Inhibition of recombinant CDK5 (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotinylated Histone H1 as substrate after 1 hr in presence of 33P-ATP by liquid scintillation counting analysis
CHEMBL1944698,CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1,3.0,nM,Inhibition of human GST-tagged CDK5
CHEMBL2103840,CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12,1.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL269881,Nc1nc(OCC2CCCCC2)c2nc[nH]c2n1,97000.0,nM,Inhibition of human CDK5 (unknown origin)
CHEMBL319467,NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1,480.0,nM,Inhibition of human CDK5 (unknown origin)
CHEMBL4092981,NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nn[nH]c3n2)cc1,3300.0,nM,Inhibition of human CDK5 (unknown origin)
CHEMBL4085238,NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3cn[nH]c3n2)cc1,5900.0,nM,Inhibition of human CDK5 (unknown origin)
CHEMBL4062554,NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3cc[nH]c3n2)cc1,4400.0,nM,Inhibition of human CDK5 (unknown origin)
CHEMBL3334979,COc1ccc(-c2cnc3scc(NC(=O)C4CCCCC4)c3c2)cc1OC,,,Inhibition of human CDK5
CHEMBL4087337,COc1ccc2c(c1)C(=O)/C(=C/c1ccc(O)c(O)c1)O2,8840.0,nM,Inhibition of human CDK5
CHEMBL490355,O=C1/C(=C/c2ccc(O)c(O)c2)Oc2cc(O)ccc21,1500.0,nM,Inhibition of human CDK5
CHEMBL4098016,COc1ccc(-c2ccnc(Nc3cccc(N)c3)n2)cc1,81000.0,nM,Inhibition of human CDK5
CHEMBL2103840,CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12,1.0,nM,Inhibition of CDK5 (unknown origin) expressed in baculovirus infected Sf9 insect cells using histone H1 as substrate after 1 hr by liquid scintillation counting analysis
CHEMBL4245507,O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1,10000.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL4294760,CSc1ncc2c(n1)CCc1cnc(Nc3ccc(C(=O)N(C)CCN(C)C)cc3)nc1-2,680.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL14762,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,160.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL4292930,Cc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@@H]3CCO)nc12,1.0,nM,Inhibition of recombinant CDK5 (unknown origin) expressed in Sf9 cells using histone H1 derived biotinylated peptide and 33P-ATP incubated for 1 hr by liquid scintillation counting method
CHEMBL4579344,Cc1cc(C)c(CNc2nc(N[C@@H](C)[C@@H](C)O)nc3c2ncn3C(C)C)cn1,232.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL2103840,CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12,1.0,nM,Inhibition of recombinant CDK5 (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotinylated-histone H1 as substrate incubated for 1 hr in presence of cyclin by [33P]-ATP-based liquid scintillation counting method
CHEMBL428690,CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1,170.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL14762,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,270.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL189963,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,10000.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL2103840,CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12,1.0,nM,Inhibition of recombinant CDK5 (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotinylated peptide as substrate after 1 hr in presence of [33P]ATP by TopCount scintillation counting method
CHEMBL428690,CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1,170.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL14762,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,200.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL2103840,CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12,1.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL4459754,CC(C)c1cnn2c(NCc3ccccc3)cc(NC[C@@H]3CCNC[C@H]3O)nc12,9000.0,nM,Inhibition of CDK5 (unknown origin) by luciferase reporter gene assay
CHEMBL4303287,CN(C)C/C=C/C(=O)Nc1cccc(C(=O)Nc2cccc(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)c2)c1,222.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL4297488,CC(C)c1cnn2c(NCc3ccccc3)cc(NC[C@H]3CCNC[C@@H]3O)nc12,9400.0,nM,Competitive reversible inhibition of CDK5 (unknown origin)
CHEMBL3655762,CC[C@H](Nc1nc(NCc2cnc(C)cc2C)c2ncn(C(C)C)c2n1)[C@@H](C)O,23.0,nM,Competitive reversible inhibition of CDK5 (unknown origin)
CHEMBL1234833,CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12,30.0,nM,Competitive reversible inhibition of CDK5 (unknown origin)
CHEMBL1801932,CC(C)c1cnn2c(NCc3ccccc3)cc(NCCCCCCN)nc12,3000.0,nM,Competitive reversible inhibition of CDK5 (unknown origin)
CHEMBL103667,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1,1000.0,nM,Inhibition of human CDK5
CHEMBL1801932,CC(C)c1cnn2c(NCc3ccccc3)cc(NCCCCCCN)nc12,3000.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL4297488,CC(C)c1cnn2c(NCc3ccccc3)cc(NC[C@H]3CCNC[C@@H]3O)nc12,9400.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL4303287,CN(C)C/C=C/C(=O)Nc1cccc(C(=O)Nc2cccc(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)c2)c1,134.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL14762,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,200.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL4462530,CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CC(C)(C)C4)c(Cl)cn2)C1,1270.0,nM,Inhibition of CDK5 (unknown origin) in presence of 5 mM ATP
CHEMBL4754081,CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CC(C)(C)C4)c(F)cn2)C1,2780.0,nM,Inhibition of CDK5 (unknown origin) in presence of 5 mM ATP
CHEMBL4754399,CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CCCC4)c(Cl)cn2)C1,4100.0,nM,Inhibition of CDK5 (unknown origin) in presence of 5 mM ATP
CHEMBL428690,CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1,170.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL4442620,C[C@@H](O)[C@@H](C)Oc1nc(Nc2ccc(S(=N)(=O)C3CC3)cc2)ncc1C(F)(F)F,10.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL4764173,CC[C@H](Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1)[C@@H](C)O,21.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL2103840,CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12,1.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL445813,O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl,13.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL1944698,CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1,4.0,nM,Inhibition of human CDK5
CHEMBL2103840,CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12,1.0,nM,Inhibition of recombinant CDK5 (unknown origin) expressed in baculovirus infected Sf9 cells using biotinylated Histone H1 peptide as substrate incubated for 1 hr in presence of [33P]ATP by liquid scintillation counting method
CHEMBL4864688,O=C(CCCOc1ccc(CC(=O)Nc2cc(C3CCC3)[nH]n2)cc1)NCCCCNc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O,7.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL4846069,COc1ccc(CC(=O)Nc2cc(C3CCC3)[nH]n2)cc1,32.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL2103840,CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12,1.0,nM,Inhibition of CDK5 (unknown origin) expressed in Sf9 insect cells using biotinylated peptide derived Histone H1 as substrate incubated for 1 hr in presence of [gamma33P]ATP by liquid scintillation counter method
CHEMBL5083646,COc1cc(/C=C2\S/C(=N/c3ccc(C)c(C)c3)NC2=O)ccc1OCc1ccc2ccccc2c1,10000.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL1496098,O=C1Nc2ccccc2/C1=C1\Nc2ccccc2\C1=N/O,,,Inhibition of CDK5 (unknown origin)
CHEMBL5191815,C.O=c1oc2cc(O)ccc2c2c1[nH]c1ccccc12,2700.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL1946917,O=c1oc2cc(O)ccc2c2c1[nH]c1ccc(O)cc12,720.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL5184492,C[C@H]1C[C@@H]2CN1CCn1[nH]c3c(cccc3c1=O)-c1nc3c(cccc3[nH]c1=O)O2,4500.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL2386753,COC(=N)c1nc2ccc3ncnc(Nc4ccc5c(c4)OCO5)c3c2s1,10000.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL2386761,COC(=N)c1nc2ccc3ncnc(Nc4ccc(OC)cc4)c3c2s1,10000.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL2386744,COC(=N)c1nc2ccc3ncnc(Nc4ccc(Br)cc4F)c3c2s1,10000.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL2103840,CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12,1.0,nM,Inhibition of Cdk5 (unknown origin)
CHEMBL14762,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,0.2,nM,Inhibition of CDK5 (unknown origin)
CHEMBL384304,COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N,0.1,nM,Inhibition of CDK5 (unknown origin) by kinase selectivity assay
CHEMBL5171657,CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(C3CCCC[C@H]3CCO)nc12,1.0,nM,Inhibition of recombinant CDK5 (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotinylated-histone H1 as substrate incubated for 1 hr in presence of 33P-ATP by liquid scintillation counter method
CHEMBL133342,CC[C@@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,200.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL5178166,O=C1NC(=O)C(c2cn3c4c(cc(F)cc24)CN(C(=O)N2CCCCC2)CC3)=C1c1cn2ccccc2n1,79.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL428690,CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1,170.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL3905910,CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccc(C(F)(F)F)cc4Cl)oc23)[C@@H]1CO,210.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL3655762,CC[C@H](Nc1nc(NCc2cnc(C)cc2C)c2ncn(C(C)C)c2n1)[C@@H](C)O,21.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL1922219,CC[C@H](Nc1nc(NCc2cccnc2)c2ncn(C(C)C)c2n1)[C@@H](C)O,70.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL2103840,CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12,5.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL296468,CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1,340.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL3656841,COC[C@@H](C)N[C@H]1CC[C@H](Nc2cc(-c3cccc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1,1050.0,nM,Inhibition of CDK5 (unknown origin) by Kinomescan method
CHEMBL5199065,CCC(CC)c1cc(N[C@H]2CC[C@H](N)C2)n2nccc2n1,1200.0,nM,Inhibition of CDK5 (unknown origin) incubated for 120 mins in presence of ATP by HotSpot kinase assay
CHEMBL5285499,CCCc1cc(N[C@@H]2CC[C@@H](N)C2)n2nccc2n1,1200.0,nM,Inhibition of CDK5 (unknown origin) incubated for 120 mins in presence of ATP by HotSpot kinase assay
CHEMBL14762,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,160.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL2103840,CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12,1.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL1230607,CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C,5.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL269538,COc1ccc2c(c1)[nH]c1c(C)nccc12,8000.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL5200447,Cc1[nH]cnc1-c1nccc2c1[nH]c1ccccc12,5000.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL5288241,C=CC(=O)Nc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cncc(NC[C@@H](O)c5ccccc5)c4)cc23)cc1,10000.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL5266005,CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@@H]3CCO)nc12,1.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL5270781,CC1CN(c2ccncc2NC(=O)c2ccnn3cc(-c4ccccc4)nc23)CCO1,6400.0,nM,Inhibition of CDK5 (unknown origin)
CHEMBL2103840,CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12,1.0,nM,Inhibition of CDK5 (unknown origin)
